BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cacabelos R, Carrera I, Martínez-Iglesias O, Cacabelos N, Naidoo V. What is the gold standard model for Alzheimer's disease drug discovery and development? Expert Opin Drug Discov 2021;:1-26. [PMID: 34330186 DOI: 10.1080/17460441.2021.1960502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Theiss EL, Griebsch LV, Lauer AA, Janitschke D, Erhardt VKJ, Haas EC, Kuppler KN, Radermacher J, Walzer O, Portius D, Grimm HS, Hartmann T, Grimm MOW. Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells. Cells 2022;11:2574. [DOI: 10.3390/cells11162574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Souza Saturnino V, Pereira de Lira Uchoa D, Peixoto de Queiroz A. ADUCANUMAB E A PROMESSA PARA O FUTURO DO TRATAMENTO DO ALZHEIMER: UMA REVISÃO SISTEMÁTICA. rc 2022;2:658-676. [DOI: 10.56083/rcv2n3-031] [Reference Citation Analysis]
3 Francesca F, Caitlin A, Sarah L, Robyn GL. Antroquinonol administration in animal preclinical studies for Alzheimer's disease (AD): A new avenue for modifying progression of AD pathophysiology. Brain, Behavior, & Immunity - Health 2022;21:100435. [DOI: 10.1016/j.bbih.2022.100435] [Reference Citation Analysis]
4 Brown RE. Genetically modified mice for research on human diseases: A triumph for Biotechnology or a work in progress? The EuroBiotech Journal 2022;6:61-88. [DOI: 10.2478/ebtj-2022-0008] [Reference Citation Analysis]
5 Martínez-Iglesias O, Naidoo V, Carrera I, Cacabelos R. Epigenetic Studies in the Male APP/BIN1/COPS5 Triple-Transgenic Mouse Model of Alzheimer's Disease. Int J Mol Sci 2022;23:2446. [PMID: 35269588 DOI: 10.3390/ijms23052446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]